Target Name: OR1N2
NCBI ID: G138882
Review Report on OR1N2 Target / Biomarker Content of Review Report on OR1N2 Target / Biomarker
OR1N2
Other Name(s): olfactory receptor OR9-23 | Olfactory receptor 1N2 | OR1N2_HUMAN | Olfactory receptor OR9-23 | olfactory receptor family 1 subfamily N member 2 | Olfactory receptor family 1 subfamily N member 2 | OR9-23 | Olfactory receptor, family 1, subfamily N, member 2

OR1N2: A GPCR Receptor in The Olfactory System

OR1N2 (Olfactory Receptor OR9-23) is a protein that is expressed in the olfactory system of the human body. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a key role in cellular signaling. The GPCR family includes many different subtypes, of which OR1N2 is one of them.

OR1N2 is a 150 amino acid protein that is expressed in the olfactory system of the human body. It is a member of the GPCR family, which is characterized by the presence of a transmembrane domain, a catalytic domain, and a carboxylic acid terminator. The transmembrane domain is responsible for the protein's ability to interact with ligands, the catalytic domain is responsible for the protein's ability to catalyze chemical reactions, and the carboxylic acid terminator is responsible for the protein's ability to bind to its ligand and activate its intracellular signaling cascade.

OR1N2 is highly expressed in the olfactory system, including the olfactory epithelium, olfactory cavity, and olfactory cells beneath the olfactory epithelium. It is also expressed in other tissues and cells, including the brain, heart, and pancreas. It is involved in the function of the olfactory system, which is responsible for the sense of smell. OR1N2 plays a key role in this process by mediating the signaling cascade that transmits sensory information from the olfactory system to the brain.

OR1N2 has also been shown to be involved in several other cellular processes, including cell signaling, neurodegeneration, and pain perception. For example, studies have shown that OR1N2 is involved in the regulation of neurogenesis, the process by which new neurons are generated in the brain, and that it is involved in the regulation of pain perception.

Due to its involvement in several cellular processes, OR1N2 has generated a lot of interest as a potential drug target. One approach to targeting OR1N2 is to use small molecules, such as drugs that can modulate its activity. Researchers have shown that inhibitors of OR1N2 can be effective in blocking pain perception and modulating neurogenesis.

Another approach to targeting OR1N2 is to use antibodies that can specifically recognize and target the protein. This approach has been used to study the role of OR1N2 in several cellular processes, including pain perception and neurogenesis. Researchers have shown that antibodies against OR1N2 can be effective in blocking pain perception and modulating neurogenesis.

In conclusion, OR1N2 is a protein that is expressed in the olfactory system of the human body and is involved in several cellular processes, including cell signaling, neurodegeneration, and pain perception. It has also been shown to be a potential drug target, with inhibitors and antibodies being developed to specifically recognize and target the protein. Further research is needed to fully understand the role of OR1N2 in cellular signaling and its potential as a drug target.

Protein Name: Olfactory Receptor Family 1 Subfamily N Member 2

Functions: Odorant receptor

The "OR1N2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR1N2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4 | OR2B11 | OR2B2 | OR2B3 | OR2B6 | OR2C1 | OR2C3 | OR2D2 | OR2D3 | OR2F1 | OR2F2 | OR2G2 | OR2G3 | OR2G6 | OR2H1 | OR2H2 | OR2I1P | OR2J1 | OR2J2 | OR2J3 | OR2J4P | OR2K2 | OR2L13 | OR2L1P | OR2L2 | OR2L3 | OR2L5 | OR2L8 | OR2L9P | OR2M1P | OR2M2 | OR2M3 | OR2M4 | OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12